Automera
PrivateLast Round
Seed
Aug 7, 2026
Total Funding Raised
$16M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Automera is a biotechnology company that develops autophagy-targeting chimera small molecules (AUTACs) for targeted protein degradation to treat cancer, inflammation, and central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Automera Comparables
Compare Automera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AUTOTAC Bio | 89% | |
| Casma Therapeutics | 86% | |
| Attec Biotech | 85% | |
Automera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 7, 2026 | ||||
| Series A | Sep 27, 2023 |
Automera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accelerator Life Science Partners | Series A |
| Xora Innovation | Series A |
| ClavystBio | Series A |
| EDBI | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 145% MoM, reaching 2.6K.
- Aug 7, 2026
$1M raised in Seed Round.
Automera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Automera's valuation, stock price, and market status.